4 | AXAHY Financials 07/16/2014 00:19:21 AXA Period | Emylers | 07/16/2014 1:19:19 AM |
3 | Latest Axa Sa ADR (AXAHY) Headlines Savoy's 100 | Stock_Tracker | 03/09/2014 12:00:56 AM |
2 | AXAHY 25.92 Stock Charts $AXAHY 1 Month Chart | chartguy89 | 03/06/2014 1:00:57 AM |
1 | AXAHY Stock Charts Sunday, February 23, 2014 at | chartguy89 | 02/23/2014 4:04:53 AM |
Recent Articles
- Insights on Apax Global Alpha Limited's Disclosure Position
- Rathbones Group Plc Reveals Financial Interests in Assura Plc
- Breadboard Welcomes Nemanja Jokanovic as New Sales VP
- Victoria's Secret & Co. Announces Upcoming Earnings Call Webcast
- Trump's New Tariffs: Economic Strategy or Potential Downfall?
- Genie Energy Reports Strong Q2 2025 Growth and Challenges
- Transforming Clarence Square: A Green Haven in Downtown
- Cars.com: Impressive Growth Report for Q2 2025
- Exciting Enhancements to Clarence Square Park: A Green Oasis
- Nova Ltd. Delivers Record Financial Results in Second Quarter
- Join AI Prop's Exciting Global Raffle for Dubai Experience!
- TEGNA Inc. Delivers Q2 2025 Earnings and Strategic Insights
- WhiteHorse Finance Reports Q2 Earnings and Confident Outlook
- Daxor's FDA-Approved Blood Volume Analyzer Revolutionizes Care
- Sabre Corporation's Strong Q2 2025 Earnings Release Overview
- FleishmanHillard Elevates Leadership for Global Corporate Affairs
- Insights from 3 E Network CEO Dr. Yang on Digital Assets
- Fidelity National Financial Declares Latest Dividend Payment
- Collegium Pharmaceutical: Second Quarter 2025 Financial Highlights
- Suburban Propane Partners Reveals Challenges and Insights
- Cassava Sciences Welcomes Dr. Hulihan as New CMO for Growth
- MACOM Technology Solutions Achieves Remarkable Q3 Financial Growth
- F&G Annuities & Life Announces Quarterly Dividend Payments
- Knight Therapeutics Enhances Growth and Financial Position
- Innovative AI+ Solutions Drive Technological Growth and Collaboration
- illumin Holdings Reports Impressive Q2 2025 Financial Growth
- Palvella Therapeutics Discusses Q2 2025 Financial Outcomes
- Jacobs Secures Contract for Rail Upgrades at Major Port Facility
- Knight Therapeutics' Q2 2025 Financial Success and Updates
- EverBank's Bold Move with New Subordinated Notes Offering
- Chris Layden Steps in as Kelly Services’ New CEO
- Portland General Electric Launches 475 MW Battery Systems
- Y-mAbs Therapeutics Prepares to Share Q2 2025 Insights
- Cassava Sciences Welcomes Dr. Joseph Hulihan as CMO
- Assessing India's Economic Risk Amid US Tariff Challenges
- Kelly Appoints Chris Layden as New CEO to Drive Growth
- illumin Holdings Inc. Reports Impressive Q2 Performance
- Y-mAbs Therapeutics Set to Reveal Q2 Financial Results Shortly
- Jacobs Unveils Major Rail Upgrade to Boost Port Operations
- Black Diamond Therapeutics Achieves Key Milestones in Q2 2025
- Jim Cramer Shares Insights on Challenging Financial Stocks
- InflaRx's Financial Journey and Future Prospects Explained
- The Surefire Group Achieves Recognition in Growing Business Sector
- VanWest Partners Launches ClearHome Self Storage Facility
- Three Undervalued Energy Stocks Poised For Recovery Ahead
- Two Tech Giants in Focus: Risks and Rewards in Q3
- Firefly Fiber Broadband Chooses Corero for Enhanced DDoS Security
- 1911 Gold Achieves Significant Gold Intercepts at True North
- Significant Share Transfers at Nokia Corporation's Incentive Plans
- Exciting Assay Results Extend Outcrop Silver's Los Mangos Vein